Book a demo

Patent Drafting Analysis of Shin-Etsu Chemical’s Silicone Oil Compound for Defoaming Agent | US 2024/0199844 A1

Patent Drafting Analysis of Shin-Etsu Chemical’s Silicone Oil Compound for Defoaming Agent | US 2024/0199844 A1
IP Drafting Analysis · US 2024/0199844 A1

Patent Drafting Analysis of Shin-Etsu Chemical's Silicone Oil Compound for Defoaming Agent | US 2024/0199844 A1

A structural and strategic analysis of US 2024/0199844 A1 covering claim architecture, drafting quality signals, prosecution positioning, and critical gaps in Shin-Etsu Chemical's crosslinked silicone defoaming oil compound patent.

US 2024/0199844 A1Filed: Mar 29, 2022Published: Jun 20, 2024C08K 3/36B01D 19/04C08J 3/20C08L 83/04
Spec Words
8,400
Across 7 sections
Draft now ↗
Total Claims
10
5 independent · 5 dependent
Draft now ↗
Figure Sheets
0
No figures; data in Table 1 (working/comparative examples)
Draft now ↗
Published by PatSnap Insights Team · · 12 min read Verified by PatSnap Eureka Data
Overview

Structural Overview

The detailed description dominates at approximately 62% of total words, with particularly dense working examples (Table 1, paragraphs [0110]–[0153]) and component chemistry disclosures across eight component subsections. The claim set is compact at 10 claims total — 5 independent and 5 dependent — covering a silicone oil compound (Claims 1–5), a self-emulsifying composition (Claim 6), an emulsion composition (Claim 7), and a manufacturing method (Claims 8–10). The patent contains no formal drawing figures; all experimental support is conveyed through Table 1 and textual working examples, which is characteristic of chemical composition patents in this IPC class.

Section Word Distribution

Detailed Desc. 5200 w Claims 600 w Summary 480 w Background 400 w Brief Desc. 40 w Abstract 160 w ↗ Click bars to explore

Figure Inventory — 0 Sheets

FigureDescriptionRole
TABLE 1
Comparative performance data for working examples 1–8 and comparative examples 1–4, showing organopolysiloxane/silica/resin compounding ratios, median particle size (SPOS), emulsion stability, initial defoaming property, internal addition stability, and defoaming property after aging.Search in Eureka ↗
Claim support
Analysis powered by PatSnap Eureka. Patent text and figures publicly available from USPTO. Draft a Similar Patent
Claims

Claim Architecture Analysis

The patent presents 5 independent claims: Claim 1 (silicone oil compound/composition), Claim 2 (silicone oil compound with MQ resin, broader molar ratio), Claim 3 (silicone oil compound with MQ resin, narrower molar ratio), Claim 4 (alkaline catalyst-treated variant of Claim 1), Claim 6 (self-emulsifying composition), Claim 7 (emulsion-type composition), and Claims 8, 9, 10 (manufacturing methods), though actual independent claims as counted from the claim text are Claims 1, 6, 7, 8 — with Claims 2, 3, 4, 5, 9, 10 being dependent. The dependent-to-independent ratio of 1.25:1 is well below the software/materials norm of 4–8:1, signaling a lean claim set that leaves substantial fallback territory undeveloped. The structural architecture separates composition protection (Claims 1–5) from application forms (Claims 6–7) and process protection (Claims 8–10), providing tripartite coverage across product, composition, and method.

Core inventive concept: The claims address the problem of silicone defoaming agents losing sustained defoaming performance — particularly in alkaline foamed liquids — due to decomposition of siloxane bonds over time. The solution, as expressed in Claim 1, is to control the median particle size on volumetric basis of the organopolysiloxane-silica crosslinked product (measured by SPOS after toluene dilution) to a specific range of 5 to 25 μm, enabling simultaneous expression of initial defoaming, sustained alkaline defoaming, and emulsion stability when the compound is emulsified.

Independent Claim Dissection

ClaimPreambleTransitionKey Body Elements
Claim 1A silicone oil compound (A) for a defoaming agent, which is a crosslink-treated product of:comprising
(a) 100 parts by mass hydrophobic organopolysiloxane, viscosity 10–100,000 mm²/s at 25°C; (b) 1–15 parts by mass fine powder silica; median particle size 5–25 μm by SPOS after toluene dilutionSearch prior art ↗
Claim 6A self-emulsifying-type defoaming agent compositioncomprising
(A) silicone oil compound of Claim 1; (B) polyoxyalkylene group-modified organopolysiloxaneSearch prior art ↗
Claim 7An emulsion-type defoaming agent compositioncomprising
(A) silicone oil compound of Claim 1; (C) surfactant; (E) waterSearch prior art ↗
Claim 8A method for producing the silicone oil compound for a defoaming agent according to claim 1comprising
Step of mixing component (b) into component (a); step of cross-linking by heating; dispersing step in mixing to adjust median particle size of crosslinked product to 5–25 μmSearch prior art ↗

Claim Dependency Tree

1 Silicone oil compound (A) for defoaming agent — crosslink-treated product of organopolysiloxane (a) + fine powder silica (b); SPOS median particle size 5–25 μmSearch Claim 1 prior art ↗
2 Adds: organopolysiloxane resin (c) composed of R¹R²R³SiO₁/₂ and SiO₄/₂ units; M/Q molar ratio 0.4–2.0Search in Eureka ↗
5 Further: compound of Claim 2 is alkaline catalyst-treated productSearch in Eureka ↗
3 Adds: organopolysiloxane resin (c) at 1.0–10 parts; M/Q molar ratio 0.6–1.0 (narrower than Claim 2)Search in Eureka ↗
4 Adds: Claim 1 compound is alkaline catalyst-treated productSearch in Eureka ↗
6 Self-emulsifying defoaming agent composition comprising Claim 1 compound (A) + polyoxyalkylene group-modified organopolysiloxane (B)Search Claim 6 prior art ↗
7 Emulsion-type defoaming agent composition comprising Claim 1 compound (A) + surfactant (C) + water (E)Search Claim 7 prior art ↗
8 Method for producing Claim 1 silicone oil compound — mixing + crosslink heating + dispersing step to achieve 5–25 μm median particle sizeSearch Claim 8 prior art ↗
9 Adds: dispersing step performed by shearing at circumferential speed 2.75–15.8 m/s using a disperserSearch in Eureka ↗
10 Adds: dispersing step via kneader — component (b) mixed into ⅓–⅕ of component (a), solid kneading at 15–30 rpm, then dilution with remaining component (a)Search in Eureka ↗
MetricThis ApplicationSpecialty Chemicals / Polymer Industry Norm
Total claims1015 – 25
Independent claim count42 – 5
Dependent : Independent ratio1.50 : 13 – 6 : 1
Method claims present?Yes — Claim 8Common
System / apparatus claims?Yes — Claim 1Always
Analysis powered by PatSnap Eureka. Patent text and figures publicly available from USPTO. Draft a Similar Patent
Drafting Quality

Drafting Quality Signals

Claim 1's particle-size characterisation via SPOS method is a technically precise and well-supported limitation that differentiates the invention from prior art, but the lean dependent claim structure (only 6 dependent claims across 4 independent claims) leaves significant prosecution fallback territory undeveloped. The specification's rich working examples (Table 1, ¶¶[0110]–[0153]) provide strong written description support for Claim 1's particle size range, while Claims 6 and 7 (composition claims) lack dependent claims adding concentration ranges or preferred component ratios that appear only in the specification.

Antecedent Basis
Antecedent basis is clean across all 10 claims. Components (a), (b), and (c) are introduced with "a" and thereafter referenced consistently. In Claim 2, "the component (a)" and "the component (b)" correctly refer back to introductory recitations in Claim 1. Claims 9 and 10 each correctly refer back to "the mixing step" introduced in Claim 8, and "the component (b)" and "the component (a)" track the antecedents in Claim 8 without ambiguity. No orphaned "the" references were identified.
Spec–Claim Consistency
All material limitations in Claim 1 are explicitly supported by the specification. The SPOS measurement method for median particle size is described in detail at ¶¶[0063]–[0064] and [0136]–[0142], providing written description support for the 5–25 μm limitation. The component (a) viscosity range of 10–100,000 mm²/s is supported at ¶[0044], and the component (b) range of 1–15 parts by mass is supported at ¶[0050]. The MQ resin molar ratios in Claims 2 and 3 are supported at ¶¶[0051]–[0057], and the method steps in Claims 8–10 are supported at ¶¶[0065]–[0074].
Transition Word Usage
All independent claims use "comprising" as the transition, which is the correct open-ended choice for chemical composition patents in this field — it allows the compound to contain additional components (surfactants, polyoxyalkylene polymers) without defeating infringement. This is strategically sound given that the application-form claims (Claims 6 and 7) add such additional components. The method claims (Claims 8–10) also use "comprising," appropriately allowing for additional steps such as neutralization and filtration described at ¶[0065].
§112(f) Means-Plus-Function Risk
No means-plus-function or step-plus-function language appears in any of the 10 claims. The claims are drafted entirely in structural/compositional terms (parts by mass, viscosity ranges, molar ratios, particle size ranges, circumferential speed ranges) and process steps with specific parameter values. This is appropriate for a chemical composition patent and avoids §112(f) invocation. The method claims in Claims 8–10 recite functional outcomes ("to adjust the median particle size") but do so in a whereby-clause manner after reciting structural steps, which does not trigger §112(f).
⚠️
§101 Eligibility Risk
The claims are directed to chemical compositions and manufacturing methods, placing them squarely within §101-eligible subject matter under the machine-or-transformation test — the method claims recite physical transformation of materials via heating and mechanical shearing. However, Claim 1's core limitation is a particle size measurement result (median particle size 5–25 μm by SPOS), which is a characterisation of a physical state rather than a structural feature of the composition per se; an examiner could theoretically challenge whether this functional/property limitation sufficiently distinguishes the compound. While §101 risk is low, examiners may raise §112(b) indefiniteness challenges regarding whether the SPOS measurement uniquely defines the compound's structure.
⚠️
Dependent Claim Fallback Quality
The dependent claim fallback is thin relative to the disclosure. Claims 9 and 10 add meaningful process-parameter fallbacks (circumferential speed in Claim 9; kneader ratio and rpm in Claim 10), but Claims 4 and 5 add only the alkaline catalyst treatment feature — a single limitation that does not exploit the specification's rich disclosure of viscosity preferences (50,000–30,000 mm²/s, ¶[0044]), preferred silica surface areas (100–500 m²/g, ¶[0048]), preferred silica particle sizes (1–8 μm, ¶[0049]), or preferred component (a) ratios (75–99.5%, ¶[0045]). Claims 6 and 7 have no dependent claims at all, leaving preferred concentration ranges for components (B), (C), and (D) unprotected at any fallback level.
⚠️
Abstract Quality
The abstract describes the oil compound's structural identity (crosslink-treated product of organopolysiloxane and fine powder silica) and the key SPOS-measured particle size range (5–25 μm on volumetric basis), which correctly identifies the novel contribution. However, it does not mention the application-form claims (self-emulsifying composition, emulsion composition) or the manufacturing method claims, meaning an examiner searching the abstract alone would not identify the full scope of protection sought. The abstract also conflates the performance benefit ("sustained defoaming capability due to small level of deterioration with time") with the structural solution without clearly stating that the particle size control via the SPOS method is the inventive mechanism.
ℹ️
Figure Support Quality
This patent contains no formal drawing figures, which is common for chemical composition patents but creates a gap in prosecution strategy — examiners in chemical art units routinely rely on figures to anchor written description challenges. All experimental support is provided through Table 1 (working examples 1–8 vs. comparative examples 1–4) and textual descriptions of components. The SPOS particle size measurement, which is the single most critical claim limitation, has detailed textual support at ¶¶[0136]–[0142] but no graphical particle size distribution curves illustrating the 5–25 μm range — such curves would have strongly reinforced the characterisation of the crosslinked product and its correlation with defoaming performance.
Analysis powered by PatSnap Eureka. Patent text and figures publicly available from USPTO. Draft a Similar Patent
Scorecard

Strategic Intent Scorecard

Multi-dimensional assessment of this application's patent strategy quality, based on claim structure, specification depth, and prosecution positioning.

Claim Breadth
3.5
Prosecution Defensibility
3
Spec–Claim Consistency
4.2
Dependent Claim Coverage
2.5
Claim Type Diversity
3.8
Figure Support Quality
2.8
Breadth Prosecution Consistency Dep. Coverage Claim Types Figures
Key observation: The highest-scoring dimension is Spec–Claim Consistency (4.2/5.0) — every material limitation in Claims 1–10 maps directly to specific paragraphs in the specification (e.g., ¶¶[0044], [0050], [0051]–[0057], [0063]–[0064], [0136]–[0142]), and the working examples in Table 1 provide quantitative experimental confirmation of the 5–25 μm particle size range's performance impact. The lowest-scoring dimension is Dependent Claim Coverage (2.5/5.0) — Claims 6 and 7 have no dependent claims at all, and the existing dependents for Claim 1 (Claims 2–5) add only MQ resin variants and alkaline catalyst treatment, leaving the specification's preferred viscosity ranges, silica surface areas, silica particle sizes, and component ratios entirely unprotected as fallback positions. Practitioners advising on continuation strategy should prioritise filing dependent claims capturing the preferred numerical ranges from ¶¶[0044]–[0057] and narrow concentration ranges for Claims 6–7.
See how your own draft compares — Open Eureka IP Drafting →
Critical Gaps

3 Critical Gaps in This Claim Set

A senior-attorney lens on the three highest-priority structural weaknesses — what each exposes in prosecution and litigation, and what a stronger filing would have done differently.

🔒

3 Critical Gaps in This Claim Set

See the full attorney-level analysis of what this application leaves unprotected — and how to draft it more defensively for your own filings.

Composition claims lack concentration-range dependents No product-by-process claim on SPOS characterisation Alkaline application domain not independently claimed
Unlock Full Analysis — Free
Frequently asked questions

US 2024/0199844 A1 — key questions answered

Still have questions? PatSnap Eureka can answer them from patent data instantly. Search in Eureka
PatSnap Eureka

Ready to Draft Your Next Patent with AI?

PatSnap Eureka's AI drafting agent writes structured claims, flags coverage gaps, and positions your application for prosecution success.

Disclaimer: This analysis is generated by PatSnap Eureka AI based on publicly available patent data from the USPTO. It does not constitute legal advice and should not be relied upon as such. Patent data may be subject to change as prosecution progresses. Scores and assessments reflect automated analysis and may not capture all relevant legal or technical nuances. Always consult a qualified patent attorney for formal legal opinions on patentability, freedom to operate, or infringement.

Ask anything about this patent.
PatSnap Eureka searches patents and data to answer instantly.
Powered by PatSnap Eureka
Link copied to clipboard

Eureka built for innovation research

Eureka built for research
Domain-specific AI agents for IP, Engineering, Life Sciences, and Materials
Patents, Scientific Literature, Compounds & More Unified in One Platform
Ask, Research, Solve, Draft, and Validate Your Work from Weeks to Minutes
Try it for Free

Help us improve this page

Found incorrect or outdated information? Let us know and we'll get it fixed.